Research Articles
Preventing IRB Amendment Delays: A Strategic Guide for Researchers and Clinical Trial Professionals
This article provides a comprehensive guide for researchers, scientists, and drug development professionals to navigate the Institutional Review Board (IRB) amendment process efficiently.
Managing Multiple Protocol Versions Across Sites: A Strategic Guide for Clinical Trial Efficiency
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on navigating the complexities of managing multiple protocol versions across clinical trial sites.
Strategic Protocol Design: A Guide to Reducing Avoidable Amendments and Cutting Clinical Trial Costs
This article provides a comprehensive guide for researchers and drug development professionals on minimizing costly and time-consuming clinical trial protocol amendments.
Protocol Amendments and Consent Form Updates: A Strategic Guide for Clinical Researchers
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on managing informed consent form updates following protocol amendments.
Navigating IRB Expedited Review for Minor Changes: A Researcher's Guide to Efficient Protocol Modifications
This article provides a comprehensive guide for researchers and drug development professionals on leveraging expedited IRB review for minor changes to approved studies.
New Protocol vs. Amendment: A Strategic Guide to Faster IRB Approval and Efficient Study Design
This article provides a comprehensive decision-making framework for researchers and drug development professionals navigating the critical choice between submitting a new study protocol or amending an existing one.
Protocol Amendment Tracking: Strategies to Manage Changes, Reduce Costs and Accelerate Drug Development
For researchers and drug development professionals, protocol amendments are a costly and time-consuming reality, with 76% of clinical trials requiring changes that cost between $141,000 and $535,000 each.
Administrative Letter vs. Full Protocol Amendment: A Strategic Guide for Clinical Researchers
This article provides clinical researchers and drug development professionals with a comprehensive guide to navigating the critical decision between submitting a full protocol amendment and an administrative letter.
A Researcher's Guide to Documenting Protocol Changes for IRB Review
This guide provides researchers, scientists, and drug development professionals with a comprehensive framework for navigating the process of documenting and submitting changes to research protocols for IRB review.
Strategic Implementation of Protocol Amendments in Multi-Site Clinical Trials: A Guide to Minimizing Costs and Maximizing Compliance
This article provides a comprehensive framework for researchers, scientists, and drug development professionals tasked with managing protocol amendments across multiple clinical trial sites.